UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

The Renewal of Cancer Immunotherapy

Vaccines (Basel), 2023-03, Vol.11 (3), p.592

2023

Volltextzugriff (PDF)

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5824

2021

Volltextzugriff (PDF)

Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors

Frontiers in immunology, 2019-10, Vol.10, p.2353-2353

2019

Volltextzugriff (PDF)

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma

Frontiers in immunology, 2021-10, Vol.12, p.778459-778459

2021

Volltextzugriff (PDF)

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Vaccines (Basel), 2022-06, Vol.10 (7), p.999

2022

Volltextzugriff (PDF)

Evaluation of in vivo labelled dendritic cell migration in cancer patients

Journal of translational medicine, 2004-07, Vol.2 (1), p.27-27

2004

Volltextzugriff (PDF)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

Journal of translational medicine, 2006-08, Vol.4 (1), p.36-36, Article 36

2006

Volltextzugriff (PDF)

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

Clinical & developmental immunology, 2010-01, Vol.2010 (1), p.504979

2010

Volltextzugriff (PDF)

In vitro CAR-T cell killing: validation of the potency assay

Cancer Immunology, Immunotherapy : CII, 2024-07, Vol.73 (9), p.168, Article 168

2024

Volltextzugriff (PDF)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

Journal of translational medicine, 2010-06, Vol.8 (1), p.52-52, Article 52

2010

Volltextzugriff (PDF)

A New Gene Family Including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: Characterization from Yeast to Human and Identification of DSCR1-like 2, a Novel Human Member (DSCR1L2)

Genomics (San Diego, Calif.), 2000-03, Vol.64 (3), p.252-263

2000

Volltextzugriff (PDF)

Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14025-e14025

2023

Volltextzugriff (PDF)

Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone

Cytotherapy (Oxford, England), 2018-06, Vol.20 (6), p.851-860

2018

Volltextzugriff (PDF)

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

Journal of translational medicine, 2013-05, Vol.11 (1), p.135-135

2013

Volltextzugriff (PDF)

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)

BMJ open, 2018-08, Vol.8 (8), p.e021701-e021701

2018

Volltextzugriff (PDF)

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

Melanoma research, 2017-08, Vol.27 (4), p.351-357

2017

Volltextzugriff (PDF)

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study

Journal of translational medicine, 2014-07, Vol.12 (1), p.209-209, Article 209

2014

Volltextzugriff (PDF)

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose interleukin-2: Interim analysis data

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14007-e14007

2015

Volltextzugriff (PDF)

Human embryo immune escape mechanisms rediscovered by the tumor

Immunobiology (1979), 2009-01, Vol.214 (1), p.61-76

2009

Volltextzugriff (PDF)

Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3040-3040

2013

Volltextzugriff (PDF)

Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome

Melanoma research, 2011-12, Vol.21 (6), p.524-529

2011

Volltextzugriff (PDF)

A Dendritic Cell (DC) microRNA signature predicts clinical outcome in Melanoma Patients treated with DC vaccine

Frontiers in immunology, 2013, Vol.4

2013

Volltextzugriff (PDF)

Review: Human embryo immune escape mechanisms rediscovered by the tumor

Immunobiology (1979), 2009-01, Vol.214 (1), p.61-76

2009

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(63)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Renewal of Cancer Immunotherapy

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay

Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Evaluation of in vivo labelled dendritic cell migration in cancer patients

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

In vitro CAR-T cell killing: validation of the potency assay

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

A New Gene Family Including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: Characterization from Yeast to Human and Identification of DSCR1-like 2, a Novel Human Member (DSCR1L2)

Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma

Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products

Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose interleukin-2: Interim analysis data

Human embryo immune escape mechanisms rediscovered by the tumor

Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients

Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-[alpha] in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study

A Dendritic Cell (DC) microRNA signature predicts clinical outcome in Melanoma Patients treated with DC vaccine

Review: Human embryo immune escape mechanisms rediscovered by the tumor

Suchergebnisse filtern